| Financial Year |
March 31 2023 |
| Monetary Funds |
28,829,321.80 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
135,721,842.49 |
| Advances to Suppliers |
12,919,213.40 |
| Other Receivables |
1,199,984,451.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
398,403,081.48 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
10,146,991.36 |
| Total Current Assets |
1,823,611,453.59 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
1,739,747.25 |
| Investment Properties |
-- |
| Fixed Assetes |
532,428,029.25 |
| Under-construction Projects |
172,237,301.99 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
111,247,499.20 |
| R&D expenses |
9,195,005.18 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
7,680,068.32 |
| Deferred Income Tax Assets |
212,720,510.37 |
| Other Non-Current Assets |
3,989,232.00 |
| Sub-Total of Non-Current Assets |
1,054,560,756.95 |
| Total Assets |
2,878,172,210.54 |
| Short-Term Loans |
29,296,769.30 |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
122,662,918.84 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
11,710,439.71 |
| Taxes Payable |
151,467,688.17 |
| Interest Payable |
5,648,122.37 |
| Dividend Payable |
-- |
| Other payables |
129,601,499.06 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
-- |
| Other Current Liabilities |
219,249.76 |
| Sub-Total of Current Liabilities |
453,496,282.78 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
506,822,138.70 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
27,667,600.00 |
| Sub-Total of Non-Current Liabilities |
681,085,944.40 |
| Total Liabilities |
1,134,582,227.18 |
| Paid-In Capital(Or Share Stock) |
2,294,107,827.00 |
| Capital Surplus |
1,355,476,503.73 |
| Surplus Reserve |
78,328,783.78 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-2,004,340,943.45 |
| Minority Stockholder's Interest |
20,017,812.30 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,723,572,171.06 |
| Owner's Equity（Stockholder's Equity） |
1,743,589,983.36 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
2,878,172,210.54 |
